MOTS-c Peptide Research: 7 Powerful Insights Into Mitochondrial and Metabolic Signalling
Exploring mitochondrial-derived peptides, AMPK activation, cellular stress responses, skeletal muscle metabolism, exercise biology and the current limits of human clinical evidence.
MOTS-c peptide research examines a 16-amino-acid peptide encoded within mitochondrial DNA and its potential role in metabolic regulation, cellular stress responses and communication between mitochondria and the cell nucleus.
MOTS-c is short for mitochondrial open reading frame of the 12S rRNA type-c. The peptide was described in a landmark 2015 study published in Cell Metabolism, which identified a previously unrecognised short open reading frame within the mitochondrial genome.
The discovery challenged the traditional view of mitochondria as organelles primarily responsible for energy production. It suggested that mitochondrial DNA could also encode short regulatory peptides capable of influencing cellular metabolism.
Subsequent studies examined MOTS-c in relation to AMP-activated protein kinase (AMPK), folate metabolism, purine biosynthesis, skeletal muscle activity and adaptive responses to metabolic stress.
In 2021, researchers reported that endogenous MOTS-c levels increased during exercise in a small human study. The same investigation found that experimental MOTS-c administration influenced physical performance and metabolic responses in mice.
These results have attracted interest in the peptide’s possible relationship with metabolic health, exercise physiology and ageing.
However, an essential distinction remains: human studies measuring naturally occurring MOTS-c are not evidence that administering synthetic MOTS-c improves human health or physical performance.
As of October 2026, clinical efficacy and safety evidence for administered native MOTS-c remains insufficient. An FDA scientific review presented in July 2026 also highlighted the lack of human safety data for MOTS-c-related drug substances.
This guide examines seven major findings, their underlying mechanisms and the analytical considerations relevant to laboratory research.
1. What Is MOTS-c? A Peptide Encoded by Mitochondrial DNA
Mitochondria are organelles involved in energy metabolism, cellular signalling and the regulation of several stress-response pathways.
They also contain their own genetic material, known as mitochondrial DNA.
The Mitochondrial Genome
Human mitochondrial DNA is a circular genome approximately 16.6 kilobases long.
It contains genes traditionally associated with respiratory-chain proteins, ribosomal RNAs and transfer RNAs.
Research has also identified short open reading frames that can produce biologically active peptides.
These compounds are collectively discussed as mitochondrial-derived peptides.
The Discovery of MOTS-c
In 2015, Lee and colleagues identified a short open reading frame within the mitochondrial 12S ribosomal RNA region.
The researchers reported that this sequence encoded a 16-amino-acid peptide.
They named it MOTS-c.
MOTS-c Molecular Characteristics
| Property | Scientific information |
|---|---|
| Compound | MOTS-c |
| Full designation | Mitochondrial open reading frame of the 12S rRNA type-c |
| Amino acid length | 16 residues |
| Commonly reported sequence | MRWQEMGYIFYPRKLR |
| Approximate molecular mass | 2,174.6 Da for the unmodified peptide |
| Genetic origin | Short open reading frame within mitochondrial DNA |
| Research classification | Mitochondrial-derived peptide |
| Major research areas | AMPK signalling, metabolic stress, skeletal muscle biology and ageing |
| Human therapeutic effectiveness | Not established |
The molecular mass refers to the unmodified sequence. A supplied peptide salt or formulated research material may have different analytical specifications.
Where Is MOTS-c Produced?
Although its coding sequence is located in mitochondrial DNA, the original study proposed that MOTS-c translation occurs in the cytoplasm using the standard genetic code.
This is an important distinction.
A peptide can be encoded by mitochondrial DNA without necessarily being translated by the mitochondrial protein-synthesis machinery.
Why This Discovery Matters
Mitochondria can influence the rest of the cell through metabolites, reactive signalling molecules and other communication systems.
MOTS-c adds another potential mechanism: a small peptide encoded by mitochondrial genetic material that influences cellular responses.
Is MOTS-c a Mitochondrial Hormone?
MOTS-c has sometimes been described as a mitochondrial hormone or mitokine.
These terms reflect interest in its possible signalling functions.
However, the terminology should not be interpreted as proof that all endocrine actions, receptors or physiological roles have been conclusively characterised.
2. MOTS-c Mechanism of Action: AMPK and Metabolic Regulation
One of the most important findings in MOTS-c peptide research concerns AMPK.
AMPK stands for AMP-activated protein kinase.
It is a central regulator of cellular energy balance.
What Does AMPK Do?
AMPK responds to changes in cellular energy status and other upstream signals.
When activated, it can influence processes involved in energy production, energy consumption and metabolic adaptation.
Its effects depend on the tissue and physiological context.
The 2015 Metabolic Study
Lee and colleagues investigated how MOTS-c affected metabolism in cultured cells and mice.
They reported changes in folate-associated metabolism and de novo purine biosynthesis.
These changes were linked to AMPK activation.
What Is the Folate Cycle?
The folate cycle participates in one-carbon metabolism.
It contributes to processes required for nucleotide synthesis and other cellular reactions.
What Is Purine Biosynthesis?
Purines are components of molecules such as ATP, GTP, DNA and RNA.
Cells produce purine nucleotides through several interconnected metabolic pathways.
MOTS-c and AICAR
The original study reported increased levels of AICAR, an intermediate associated with purine biosynthesis.
AICAR-related metabolic changes can contribute to AMPK activation.
The investigators therefore proposed a pathway connecting MOTS-c-associated changes in folate and purine metabolism with AMPK signalling.
Does MOTS-c Directly Bind AMPK?
The original findings do not establish MOTS-c as a direct AMPK-binding agonist.
Instead, they support a mechanism involving upstream metabolic changes that influence AMPK activity.
Why This Distinction Matters
A compound may change AMPK phosphorylation or downstream signalling without binding directly to AMPK.
Describing such a compound as a direct AMPK activator can oversimplify the mechanism.
AMPK Is Not a Universal Weight-Loss Switch
AMPK regulates numerous processes, but activation of an energy-sensing pathway does not automatically translate into clinically meaningful weight loss.
Metabolic outcomes depend on the organism, tissue, experimental conditions and broader physiological environment.
What Can Be Concluded?
Preclinical research supports a relationship between MOTS-c-associated metabolic changes and AMPK signalling.
The precise contribution of this mechanism to human physiology and the effects of administered synthetic MOTS-c require further investigation.
3. MOTS-c and Skeletal Muscle Metabolism
Skeletal muscle is a major site of glucose utilisation and energy expenditure.
It is therefore an important tissue in metabolic research.
Why Skeletal Muscle Matters
Muscle cells require ATP for contraction, maintenance and adaptation.
They can use several energy substrates, including glucose and fatty acids.
Changes in substrate utilisation may influence cellular metabolic responses.
MOTS-c and Glucose Metabolism
The 2015 study reported changes in glucose-related metabolic outcomes in experimental cell systems.
The researchers also examined glycolytic responses and mitochondrial oxygen consumption.
What Is Glycolysis?
Glycolysis is a metabolic pathway that converts glucose into smaller molecules while generating energy-related intermediates.
Its activity can change in response to cellular demands.
Does MOTS-c Increase Glycolysis?
Selected laboratory models have shown MOTS-c-associated changes in glycolytic measurements.
However, these findings depend on the experimental system.
They should not be interpreted as proof that MOTS-c universally increases glucose utilisation in humans.
Insulin Sensitivity in Mouse Models
The original research reported that MOTS-c administration influenced insulin-related metabolic outcomes in mice exposed to particular dietary or age-related conditions.
These results were relevant to experimental models of insulin resistance.
What Is Insulin Sensitivity?
Insulin sensitivity describes how responsive cells and tissues are to insulin-associated metabolic signals.
It is influenced by numerous factors, including tissue type, nutritional state and physiological conditions.
Does MOTS-c Treat Human Insulin Resistance?
No human clinical evidence currently establishes native MOTS-c as an effective treatment for insulin resistance.
The mouse findings provide a basis for further study, not a clinical conclusion. MOTS-c peptide research
MOTS-c and Muscle Growth
Research involving muscle metabolism should not be confused with evidence of muscle hypertrophy. MOTS-c peptide research
Changes in metabolic signalling or exercise performance in mice do not establish increased human muscle mass.
Research Implications
MOTS-c provides a useful experimental subject for studying relationships among mitochondrial signalling, energy metabolism and skeletal muscle responses.
The strongest conclusions remain specific to the models in which the effects were observed.
4. MOTS-c Exercise Research: What the Human Study Actually Found
Exercise physiology is one of the most frequently discussed areas of MOTS-c research.
The 2021 study published in Nature Communications is particularly important because it included measurements in humans.
The Human Exercise Experiment
Researchers examined 10 healthy young male participants who performed a cycling exercise session.
They measured endogenous MOTS-c in skeletal muscle and circulation. MOTS-c peptide research
What Happened to MOTS-c Levels?
The investigators reported increased MOTS-c measurements following exercise.
Circulating levels increased during and shortly after the exercise session before returning toward baseline.
Muscle measurements also showed a substantial relative increase following exercise. MOTS-c peptide research
What Does This Establish?
The study provides evidence that endogenous MOTS-c responds to exercise under the conditions examined.
It supports investigating MOTS-c as a potential component of exercise-associated signalling. MOTS-c peptide research
What Does It Not Establish?
The participants were not enrolled in a clinical trial testing administered synthetic MOTS-c for performance improvement.
Therefore, the study does not establish that taking MOTS-c improves endurance, strength or exercise recovery.
Mouse Exercise Experiments
The same research programme examined MOTS-c administration in mice of different ages.
Researchers reported improvements in selected physical performance measurements. MOTS-c peptide research
Age-Related Differences
The study included young, middle-aged and older mice.
It also examined whether experimental treatment initiated late in life could influence physical capacity.
Why Mouse Results Cannot Be Directly Applied to Humans
Mice differ from humans in physiology, lifespan, metabolism and experimental exercise responses. MOTS-c peptide research
An improvement in a mouse performance test does not establish a comparable effect in human athletes or older adults.
Does MOTS-c Replace Exercise?
No.
The available findings do not support treating MOTS-c as a substitute for exercise.
The observation that exercise changes endogenous MOTS-c levels is fundamentally different from proving that administration reproduces exercise benefits. MOTS-c peptide research
Key Scientific Interpretation
The 2021 study supports a relationship between exercise and mitochondrial-derived peptide signalling.
It does not establish clinical performance-enhancing effects from synthetic MOTS-c administration in humans.
5. MOTS-c Nuclear Translocation and Cellular Stress Responses
An especially interesting aspect of MOTS-c biology concerns communication between mitochondria and the nucleus.
The nucleus contains most of the genetic information used to regulate cellular functions.
Mitochondrial–Nuclear Communication
Mitochondria communicate with the nucleus through multiple signalling pathways.
This process can help coordinate cellular responses to metabolic conditions.
What Is Nuclear Translocation?
Nuclear translocation occurs when a molecule moves from the cytoplasm into the nucleus.
Such movement can alter interactions with nuclear proteins and influence gene regulation.
MOTS-c and Stress Conditions
Experimental studies have reported that MOTS-c can accumulate in the nucleus under selected metabolic stress conditions.
These observations have supported the hypothesis that MOTS-c participates in adaptive cellular signalling.
Gene Expression Changes
Research has associated MOTS-c with changes in the expression of genes involved in metabolic responses and cellular stress adaptation.
However, altered gene expression does not necessarily establish a direct interaction with DNA.
What Is a Transcription Factor?
A transcription factor is a protein that regulates gene expression through interactions with DNA or transcriptional machinery.
MOTS-c should not automatically be classified as a conventional transcription factor.
Its reported nuclear effects may involve interactions with other regulatory proteins.
Heat Shock Factor 1
Heat shock factor 1, or HSF1, is involved in cellular responses to proteotoxic and other forms of stress.
The 2021 research examined HSF1-dependent responses in experimental muscle-cell systems.
Why HSF1 Matters
Cells must maintain protein quality and adapt to changing conditions.
HSF1 participates in gene-expression programmes relevant to these processes.
Does MOTS-c Directly Activate HSF1?
The reported experimental dependence on HSF1 does not, by itself, establish direct molecular binding.
The relationship may involve additional signalling events. MOTS-c peptide research
What Can Be Concluded?
Preclinical research supports a role for MOTS-c in adaptive stress-related signalling, including changes in nuclear gene expression.
The full molecular mechanism and its significance for human clinical outcomes remain incompletely characterised.
6. MOTS-c Research in Ageing and Metabolic Stress
Ageing is associated with changes in mitochondrial function, metabolic regulation and cellular stress responses.
MOTS-c has therefore attracted attention in experimental ageing research.
Ageing and Mitochondrial Biology
Mitochondrial function can change with age. MOTS-c peptide research
However, ageing is not caused by a single pathway or organelle. MOTS-c peptide research
It involves interacting biological processes across multiple tissues. MOTS-c peptide research
MOTS-c Levels and Age
Some observational studies have examined relationships between circulating MOTS-c concentrations, age and metabolic characteristics.
These associations can generate hypotheses.
They do not establish causation.
Mouse Ageing Research
The 2021 Nature Communications study examined MOTS-c in older mice.
The researchers reported changes in selected physical performance outcomes.
What Is Healthspan?
Healthspan generally refers to the period of life spent in relatively good health or functional condition.
It is distinct from lifespan. MOTS-c peptide research
Does MOTS-c Extend Human Lifespan?
There is no reliable human clinical evidence establishing that MOTS-c extends lifespan.
Does MOTS-c Reverse Ageing?
No.
The available studies do not support claims that MOTS-c reverses human biological ageing.
Metabolic Stress Adaptation
MOTS-c has been examined in relation to how cells respond to changes in energy availability and other stressors.
These processes are relevant to ageing research, but their relationship with long-term human health outcomes remains uncertain. MOTS-c peptide research
Why Biomarkers Are Not Clinical Outcomes
A change in AMPK activity, circulating peptide concentration or gene expression may be scientifically interesting.
It does not independently establish improved health, reduced disease risk or longer life. MOTS-c peptide research
The Appropriate Conclusion
MOTS-c is a promising subject for mechanistic ageing research.
Its potential as a human therapeutic compound remains unproven. MOTS-c peptide research
7. MOTS-c Human Clinical Evidence and Regulatory Limitations
The most important limitation in MOTS-c peptide research concerns the difference between preclinical findings and clinical evidence.
What Human Evidence Exists?
Human studies have measured naturally occurring MOTS-c levels and examined associations with exercise or metabolic characteristics.
These studies provide information about endogenous biology.
They are not equivalent to clinical trials evaluating the effects of administering synthetic MOTS-c.
Have Human Treatment Benefits Been Established?
No.
As of October 2026, reliable published evidence has not established native MOTS-c administration as an effective treatment for obesity, diabetes, exercise performance decline or ageing-related conditions. MOTS-c peptide research
What About Registered Trials?
Clinical trial registration indicates that a study is planned or underway. MOTS-c peptide research
It does not establish that a treatment is effective or safe. MOTS-c peptide research
Researchers should distinguish registered protocols from completed studies with published results. MOTS-c peptide research
What About MOTS-c Analogues?
A modified compound inspired by MOTS-c is not necessarily chemically or pharmacologically equivalent to native MOTS-c.
Results involving a modified analogue should not be attributed automatically to the native peptide. MOTS-c peptide research
FDA Scientific Review in 2026
Materials prepared for the July 2026 FDA Pharmacy Compounding Advisory Committee meeting highlighted substantial gaps in the safety evidence for MOTS-c-related bulk drug substances.
The review identified a lack of adequate human data concerning administered MOTS-c-related substances.
It also noted insufficient information to assess certain safety questions, including immunogenicity.
What Is Immunogenicity?
Immunogenicity refers to the ability of a substance to trigger an immune response.
For peptide-based compounds, this is one of several considerations that may require evaluation during pharmaceutical development.
Is MOTS-c FDA-Approved?
MOTS-c is not an FDA-approved medicine.
What About Athletic Use?
MOTS-c is relevant to anti-doping considerations because of its experimental metabolic and performance-related research.
Athletes should consult the current prohibited list and applicable rules rather than assuming that an unapproved peptide is permitted.
Why the Evidence Gap Matters
Without adequate controlled human trials, researchers cannot reliably establish effective clinical applications, appropriate safety margins or long-term consequences.
The Scientific Conclusion
MOTS-c has produced interesting experimental findings, but its therapeutic effectiveness and safety in humans remain unestablished.
MOTS-c Peptide Research: Evidence Strength by Application
| Research area | Evidence available | Appropriate interpretation |
|---|---|---|
| Mitochondrial genetic origin | Molecular and genetic research | MOTS-c is encoded by a mitochondrial DNA short open reading frame |
| AMPK signalling | Cell and animal studies | Experimental metabolic pathway effects reported |
| Folate and purine metabolism | Cell-based metabolic studies | Mechanistic changes observed |
| Skeletal muscle metabolism | Cell and animal research | Preclinical metabolic effects |
| Endogenous exercise response | Small human observational experiment | MOTS-c levels changed during and after exercise |
| Physical performance | Mouse studies | Human performance benefit not established |
| Insulin resistance | Primarily mouse studies | Human treatment efficacy not established |
| Ageing and healthspan | Preclinical research | No demonstrated human anti-ageing effect |
| Human clinical safety | Insufficient evidence | Safety cannot be established |
| Human therapeutic effectiveness | Insufficient clinical evidence | No approved therapeutic application |
MOTS-c Analytical Testing and Laboratory Quality
Reliable MOTS-c experiments depend on the identity and quality of the peptide used.
The name printed on a vial does not establish that the material contains the intended 16-amino-acid sequence.
Peptide Identity
Mass spectrometry can provide evidence supporting the expected molecular mass.
Additional techniques may be required for sequence confirmation and characterisation of related species.
HPLC Purity Testing
High-performance liquid chromatography can separate the target peptide from certain impurities.
A chromatographic main-peak area percentage is not necessarily equivalent to absolute peptide content.
LC-MS Analysis
Liquid chromatography–mass spectrometry combines separation with mass-based detection.
It can help distinguish the intended peptide from some related impurities and degradation products.
Sequence Verification
Because peptide biological activity can depend on specific amino acid residues, sequence identity matters.
A sample with an incorrect residue or modification may not behave like the material described in a published study.
Peptide Content
Total lyophilised sample mass may include water, counterions and other constituents.
Laboratories should distinguish the total mass of the material from analytically determined peptide content.
Stability
Peptide stability depends on structure, formulation and environmental conditions.
Storage recommendations should be supported by evidence applicable to the specific product format.
Batch-Specific Certificates of Analysis
A Certificate of Analysis should identify the relevant batch and provide interpretable analytical results.
A certificate is most useful when the methods and specifications match the intended research material.
Sterility and Endotoxin
HPLC and LC-MS do not independently establish sterility or endotoxin status.
These require separate testing where relevant.
Why Analytical Quality Matters
An impurity or degradation product may influence metabolic assays.
Without suitable controls and characterisation, an experimental response may be incorrectly attributed to MOTS-c.
Worked Example: Interpreting an AMPK Signalling Experiment
Consider a hypothetical experiment measuring the ratio of phosphorylated AMPK to total AMPK in cultured skeletal muscle cells.
The experiment includes an untreated control and three experimental groups.
| Experimental group | Hypothetical relative p-AMPK/AMPK ratio |
|---|---|
| Untreated control | 1.00 |
| Experimental group A | 1.25 |
| Experimental group B | 1.60 |
| Experimental group C | 1.48 |
These values are fictional and are provided only to illustrate scientific interpretation.
What Does the Experiment Show?
The experimental groups display higher relative AMPK phosphorylation than the control.
Does This Prove Direct AMPK Binding?
No.
The observed changes may result from upstream metabolic events.
Does This Prove Increased Human Fat Loss?
No.
A cell-based signalling measurement cannot establish a human clinical outcome.
What Additional Measurements Would Help?
Researchers could examine energy-related metabolites, downstream AMPK targets, cell viability and independent metabolic endpoints.
Why Are Controls Important?
Appropriate controls help distinguish a specific biological response from general cellular stress or experimental artefacts.
Main Lesson
A measurable signalling response is useful evidence for a defined laboratory question.
It is not proof of clinical effectiveness.
MOTS-c Compared With Other Metabolic Research Peptides
MOTS-c differs from receptor-targeting peptides frequently discussed in metabolic research.
| Compound | Principal research distinction | Important limitation |
|---|---|---|
| MOTS-c | Mitochondrial-derived peptide associated with metabolic stress signalling | Human therapeutic effects unestablished |
| Retatrutide | Triple GIP, GLP-1 and glucagon receptor agonist | Clinical findings concern a defined pharmaceutical compound |
| Tirzepatide | Dual GIP and GLP-1 receptor agonist | Approved pharmaceutical products are not equivalent to research materials |
| Cagrilintide | Long-acting amylin analogue with calcitonin-family receptor activity | Clinical evidence is compound- and formulation-specific |
These peptides differ in structure, biological targets and evidence base.
MOTS-c should not be described as a GLP-1 receptor agonist.
Similarly, clinical findings from tirzepatide or retatrutide studies cannot be used to establish MOTS-c effectiveness.
Related Axion Peptide Lab Research Guides
Confirm that these planned internal article URLs are live before publication.
MOTS-c Research Materials at Axion Peptide Lab
Axion Peptide Lab provides a catalogue of compounds for laboratory and analytical research.
Researchers evaluating MOTS-c should consult the current catalogue and verify the exact product specifications and available documentation.
What Should Research Laboratories Review?
Relevant information includes the declared peptide sequence, chemical form, nominal content, batch identification and analytical methods.
Why Is Batch Verification Important?
A published experiment concerns a particular compound tested under defined conditions.
Its findings do not automatically verify the identity or quality of independently supplied materials.
Does High Purity Prove Biological Effectiveness?
No.
Chromatographic purity, molecular identity, absolute peptide content and biological activity are different properties.
Research-Only Distinction
MOTS-c research materials should not be represented as approved medicines or as clinically validated treatments for metabolic or ageing-related conditions.
Frequently Asked Questions About MOTS-c Peptide Research
1. What is MOTS-c peptide research?
MOTS-c peptide research examines a mitochondrial DNA-encoded peptide and its relationship with cellular metabolism, AMPK signalling, exercise responses and metabolic stress adaptation.
2. What does MOTS-c stand for?
MOTS-c stands for mitochondrial open reading frame of the 12S rRNA type-c.
3. How many amino acids are in MOTS-c?
The commonly studied native MOTS-c peptide contains 16 amino acid residues.
4. What is the MOTS-c mechanism of action?
Preclinical studies associate MOTS-c with changes in folate and purine metabolism, AMPK signalling and adaptive cellular stress responses. Its complete mechanism remains incompletely characterised.
5. Does MOTS-c activate AMPK?
Cell and animal experiments have reported MOTS-c-associated AMPK activation. The evidence supports upstream metabolic mechanisms rather than conclusively established direct AMPK binding.
6. Is MOTS-c produced during exercise?
A small human study reported increased endogenous MOTS-c measurements during and after exercise. This does not prove that administered synthetic MOTS-c improves human exercise performance.
7. Does MOTS-c help with weight loss?
Mouse studies have reported changes in diet-associated metabolic outcomes, but reliable human clinical evidence establishing MOTS-c as an effective weight-loss treatment is lacking.
8. Is MOTS-c an anti-ageing peptide?
MOTS-c is being studied in ageing-related experimental models. It has not been shown to reverse human ageing or extend human lifespan.
9. Is MOTS-c FDA-approved?
No. MOTS-c is not an FDA-approved medicine, and human safety and therapeutic effectiveness remain insufficiently established.
10. How can laboratories verify MOTS-c purity and identity?
Relevant analytical approaches may include HPLC, LC-MS, sequence-related identity testing and batch-specific documentation appropriate to the research material.
Conclusion: What MOTS-c Peptide Research Actually Establishes
MOTS-c peptide research has expanded scientific understanding of how mitochondrial genetic material may contribute to cellular signalling.
The peptide’s discovery demonstrated that a short open reading frame within mitochondrial DNA can encode a molecule associated with metabolic regulation.
Preclinical studies have connected MOTS-c with AMPK signalling, folate and purine metabolism, skeletal muscle responses and cellular stress adaptation.
A small human exercise experiment also demonstrated changes in endogenous MOTS-c levels following physical activity.
These findings provide a scientific basis for further research.
However, the current evidence does not establish that administering synthetic MOTS-c improves human metabolic health, exercise performance or longevity.
Human clinical safety remains inadequately characterised, and results involving experimental analogues should not automatically be attributed to native MOTS-c.
For laboratories, accurate molecular identification, appropriate analytical testing and careful interpretation of experimental outcomes remain essential.
MOTS-c is an important subject in mitochondrial signalling research, but its biological potential should not be confused with established clinical effectiveness.
Scientific References
- Lee C, Zeng J, Drew BG, et al. (2015). The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance. Cell Metabolism, 21(3), 443–454.
https://doi.org/10.1016/j.cmet.2015.02.009 - Reynolds JC, Lai RW, Woodhead JST, et al. (2021). MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nature Communications, 12, 470.
https://doi.org/10.1038/s41467-020-20790-0 - Kim KH, Son JM, Benayoun BA, Lee C. (2018). The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress. Cell Metabolism.
https://pubmed.ncbi.nlm.nih.gov/?term=Kim+MOTS-c+translocates+nucleus+2018 - United States Food and Drug Administration. (2026). Pharmacy Compounding Advisory Committee Meeting: MOTS-c-Related Bulk Drug Substances, Clinical Safety Review.
https://www.fda.gov/media/193773/download - ClinicalTrials.gov. Registered studies involving MOTS-c and related research compounds.
https://clinicaltrials.gov/search?term=MOTS-c - PubMed. Biomedical literature on mitochondrial-derived peptides and MOTS-c.
https://pubmed.ncbi.nlm.nih.gov/?term=MOTS-c - IUPHAR/BPS Guide to Pharmacology. Reference database for molecular signalling and pharmacology.
https://www.guidetopharmacology.org/
These references concern published scientific findings and regulatory evidence reviews. They do not establish the identity, purity, safety or clinical equivalence of independently supplied research materials.
Research-use notice: This article is provided for scientific education and legitimate laboratory research. Axion Peptide Lab research materials are not intended for human or veterinary administration. Findings from animal models, cellular experiments and studies of endogenous MOTS-c should not be interpreted as medical advice, administration guidance or established claims of human therapeutic benefit.
One Response